by TractManager | Feb 23, 2017 | Clinical Utility Evaluation
The morbidity and mortality associated with chronic and acute infections are substantial, and antimicrobial-resistant pathogens are a global threat. Although there are numerous methods that can be used to identify a pathogen and its resistance profile, these methods...
by TractManager | Feb 16, 2017 | Clinical Utility Evaluation
The morbidity and mortality associated with chronic and acute infections are substantial, and antimicrobial-resistant pathogens are a global threat. Although there are numerous methods that can be used to identify a pathogen and its resistance profile, these methods...
by TractManager | Feb 16, 2017 | Clinical Utility Evaluation
The morbidity and mortality associated with chronic and acute infections are substantial, and antimicrobial-resistant pathogens are a global threat. Although there are numerous methods that can be used to evaluate the resistance profile of these pathogens, these...
by TractManager | Feb 16, 2017 | Clinical Utility Evaluation
This report evaluates the clinical utility of fragile X syndrome (FXS) genetic testing. The evidence is considered for use of genetic testing to diagnose individuals with suspected disease; carrier testing for women with and without a family history of intellectual...
by TractManager | Feb 16, 2017 | Health Technology Assessment
Purpose of Technology: Antibiotic bone cement (ABC) is a type of curable polymethylmethacrylate preparation created by adding various antibiotic medications to plain, nonmedicated bone cement. Most commonly, ABC is used to treat infected total joint prostheses as part...
Recent Comments